Arch Phys Med Rehabil
December 2002
Objectives: To describe the efficacy of intrathecal baclofen (ITB) therapy in the management of spasticity in young children with cerebral palsy (CP) and to identify risk factors for complications.
Design: Consecutive case series of 25 implanted ITB delivery systems during a 48-month period.
Setting: Pediatric specialty hospital and outpatient department.